Skip to main content
hello world

BriaCell Therapeutics: Bottom 25 Performing Stocks Year-to-Date on TSX (BCT)

AI-generated - The Globe and Mail - Thu Apr 25, 6:40AM CDT

BriaCell Therapeutics Corp is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.

This report is generated monthly. It highlights the 25 companies with the greatest percentage decrease in share price year-to-date. Stocks in this category are generally sold to preserve capital or held for speculation.

Companies experiencing dramatic increases in share price can do so for a variety of reasons – including bearish changes in sector outlook, or the company is experiencing financial difficulties generally due to an inability to service its debt.

SymbolNameTotal ReturnPeriod
HZMHorizonte Minerals PLC-94.736842YTD
TAIGTaiga Motors Corp-70.786517YTD
ATEAntibe Therapeutics Inc-68.27957YTD
BCTBriaCell Therapeutics Corp-61.538462YTD
VPHValeo Pharma Inc-52.777778YTD
APSAptose Biosciences Inc-50.447761YTD
SSRMSSR Mining Inc-47.398031YTD
NPKVerde AgriTech Ltd-46.496815YTD
LEVThe Lion Electric Co-44.915254YTD
ECNECN Capital Corp-44.666667YTD
EXROExro Technologies Inc-44.53125YTD
AVNTAvant Brands Inc-42.857143YTD
NEXTNextSource Materials Inc-42.5YTD
EGLXEnthusiast Gaming Holdings Inc-42.105263YTD
CNTCentury Global Commodities Corp-40YTD
SVASernova Corp-38.571429YTD
GVCGlacier Media Inc-37.5YTD
FANSFansunite Entertainment Inc-36.363636YTD
BRMIBoat Rocker Media Inc-34.615385YTD
GRNGreenlane Renewables Inc-34.615385YTD
XTRAXtract One Technologies Inc-34.589041YTD
LPENLoop Energy Inc-33.333333YTD
NCFNorthcliff Resources Ltd-33.333333YTD
LSPDLightspeed Commerce Inc-33.069734YTD
PMETPatriot Battery Metals Inc-32.729104YTD

All data provided as of April 24, 2024.

More about BriaCell Therapeutics Corp

BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.

BriaCell Therapeutics Corp is listed under BCT on the Toronto Stock Exchange.

Artificial intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.